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Cholesterol hastens Alzheimer’s
 
esults from Qinghai Zhang, Jeffery Kelly (Scripps Research 
Institute, La Jolla, CA), and colleagues suggest that evil 
metabolites may accelerate Alzheimer’s disease (AD) by pro-
moting protein misfolding. This folding effect may explain why 
inflammation and high cholesterol are risk factors for AD.
AD results from aggregates of a misfolded form of amyloid 
 
 
 
 
peptide (A
 
 
 
). Misfolding occasionally results from processing 
flaws or mutations in the A
 
 
 
 precursor, but most patients have 
normal A
 
 
 
. Zhang et al. show that even normal A
 
 
 
 folds 
abnormally when cholesterol by-products modify it.
Cholesterol itself did not affect A
 
 
 
, but cholesterol modified 
by reactive oxygen species (which are produced during 
inflammation) to generate an aldehyde group reacted with 
A
 
 
 
 and made it more hydrophobic. This altered form 
aggregates at much lower concentrations than does normal 
A
 
 
 
–concentrations that are found in the brain.
Although brain 
samples did not 
show higher levels 
of the cholesterol 
aldehydes in AD 
patients, only small 
amounts of these 
metabolites are 
needed to jump start 
aggregation. “The 
creation of compounds that are reactive could be from an event 
occurring years before an individual presents with AD,” says 
Kelly. So, as boxers already know, one good knock on the head 
might do more lasting damage than just a fleeting headache.
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A  aggregates (white) form faster in the 
presence (right) of cholesterol aldehydes.
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RNA de-inhibition
 
mall RNAs are famous for their gene-
silencing ability. But new results 
from Tomoko Kuwabara, Fred H. Gage 
(Salk Institute, La Jolla, CA), and 
colleagues show that some tiny RNA 
species turn genes on, not off.
This new class of RNAs is needed to 
make neurons. “Small double-stranded 
RNAs exist in reasonably high concen-
trations in cells that have just committed 
to neuronal lineages,” says Gage. These 
RNAs are homologous to a promoter 
sequence called 
 
NRSE/RE-1
 
, which is 
found in a wide range of genes that are 
expressed only in neurons. In other cell 
types, these genes are known to be shut 
off by the NRSF/REST repressor.
The group shows that this repressor 
becomes an activator when 
 
NRSE
 
 dsRNAs 
S
 
The two faces of Mad2
 
equence dictates structure, 
but for Mad2, one 
structure is not enough. 
New results from groups 
led by Hongtao Yu and 
Josep Rizo (University of 
Texas Southwestern, Dallas, 
TX) show that Mad2 adopts 
two distinct conformations 
and that checkpoint acti-
vation may consist of switching Mad2 to the right form.
Mad2 holds up anaphase until every chromosome is properly 
attached to the spindle. Past structural studies of Mad2 showed that 
Mad1 (its activator), and Cdc20 (its anaphase-halting target) share 
the same binding site. “It would seem,” says Rizo, “that [Mad1] 
would be a competitor rather than an activator because they bind in 
the same place.” But the newly identified second conformation 
suggests an answer to this puzzle–Mad1 may put Mad2 in an active 
conformation that is maintained even when the Mads separate.
The two forms can be distinguished based on column chroma-
tography and NMR. The active form has a higher affinity for 
Cdc20 than does the other form and blocks anaphase in oocyte 
extracts. In vivo, sequestration of only the active form thwarts 
the checkpoint.
The forms interchange in vitro very slowly. A fragment of Mad1, 
however, accelerates transformation of the inactive into the active 
form. Some Mad2 is always complexed with Mad1 in cells, so the 
question now is what tells Mad1 to toss off Mad2 (in its active 
form) so it can bind to Cdc20. 
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Mad2 exists in inactive (left) and 
active (right) forms.
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are around. As a result, neuronal 
genes are turned on, and multi-
potent adult neural stem cells 
become neurons.
The NRSF/REST protein binds 
strongly to the dsRNA, and the 
two probably sit on promoters 
as a complex. When both are 
present, histone acetylases and 
chromatin-remodeling proteins 
replace the deacetylases and 
methyl-DNA binding proteins 
that are found at neuronal gene 
promoters when only NRSF is 
NRSE dsRNA (red) makes NRSF/REST (green) an 
activator in differentiating neurons.
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expressed.
The dsRNAs are found in regions of 
the hippocampus where neurons are 
differentiating, and their destruction 
prevents cultured cells from becoming 
neurons in response to inducing signals. 
A single molecule RNA switch that creates 
an entire lineage may not, however, be 
found outside neurons. “It’s an unusual 
case,” says Gage, “because of NRSF. It 
binds to so many promoters that it makes 
the RNAs generalizable.” 
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